Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1
George K. Lewis, Margaret E. Ackerman, Gabriella Scarlatti, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization
Bin Su, Stefania Dispinseri, Valeria Iannone, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 54
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 31
Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine
Kyle L. O’Donnell, Friederike Feldmann, Benjamin Kaza, et al.
EBioMedicine (2023) Vol. 89, pp. 104463-104463
Open Access | Times Cited: 19
Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing
Steven W. de Taeye, Angela I. Schriek, Jeffrey C. Umotoy, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 5
Role of follicular homing natural killer cells in HIV infection
Sivasankaran Munusamy Ponnan, Sakthivel Govindaraj, Vijayakumar Velu
Current Opinion in HIV and AIDS (2025)
Closed Access
The complex challenges of HIV vaccine development require renewed and expanded global commitment
Linda‐Gail Bekker, Roger Tatoud, François Dabis, et al.
The Lancet (2019) Vol. 395, Iss. 10221, pp. 384-388
Closed Access | Times Cited: 52
Immunogenicity of biologic therapies for migraine: a review of current evidence
Joshua M. Cohen, Xiaoping Ning, Yoel Kessler, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 36
Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis
David A. Spencer, Benjamin S. Goldberg, Shilpi Pandey, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Low pH Exposure During Immunoglobulin G Purification Methods Results in Aggregates That Avidly Bind Fcγ Receptors: Implications for Measuring Fc Dependent Antibody Functions
Ester López, Nichollas E. Scott, Bruce D. Wines, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 41
Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function
Rongyuan Gao, Zizhang Sheng, Chithra Sreenivasan, et al.
Viruses (2020) Vol. 12, Iss. 3, pp. 276-276
Open Access | Times Cited: 34
Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay
Matthew J. Murray, Megan McIntosh, Claire Atkinson, et al.
Journal of Infection (2021) Vol. 82, Iss. 5, pp. 170-177
Open Access | Times Cited: 31
Engineering stem cells for cancer immunotherapy
Yan-Ruide Li, Yang Zhou, Adam Kramer, et al.
Trends in cancer (2021) Vol. 7, Iss. 12, pp. 1059-1073
Closed Access | Times Cited: 29
Lymph node CXCR5+ NK cells associate with control of chronic SHIV infection
Sheikh Abdul Rahman, James M. Billingsley, Ashish Sharma, et al.
JCI Insight (2022) Vol. 7, Iss. 8
Open Access | Times Cited: 20
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates
Isabela Silva de Castro, Giacomo Gorini, Rosemarie D. Mason, et al.
iScience (2021) Vol. 24, Iss. 2, pp. 102047-102047
Open Access | Times Cited: 25
Targeting Fc effector function in vaccine design
Simone I. Richardson, Penny L. Moore
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 6, pp. 467-477
Closed Access | Times Cited: 21
Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4 + T Cell
Jérémie Prévost, Jonathan Richard, Romain Gasser, et al.
Journal of Virology (2022) Vol. 96, Iss. 6
Open Access | Times Cited: 12
Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production
James D. Dahlvang, Jenna K. Dick, Jules Sangala, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 8, pp. 1108-1122
Closed Access | Times Cited: 7
Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies
Syna Kuriakose Gift, Lindsay Wieczorek, Eric Sanders‐Buell, et al.
Journal of Virology (2023) Vol. 97, Iss. 2
Open Access | Times Cited: 6
Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response
LaTonya D. Williams, Xiaoying Shen, Sheetal Sawant, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 5, pp. e1011359-e1011359
Open Access | Times Cited: 5
Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells
Evan Rossignol, Anne‐Sophie Dugast, Hacheming Compere, et al.
Cell Reports (2021) Vol. 35, Iss. 8, pp. 109167-109167
Open Access | Times Cited: 13
Vaccine Platform Comparison: Protective Efficacy against Lethal Marburg Virus Challenge in the Hamster Model
Kyle L. O’Donnell, Corey W. Henderson, Hanna Anhalt, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8516-8516
Open Access | Times Cited: 1
Functional comparison of Fc-engineering strategies to improve anti-HIV-1 antibody effector functions
Angela I. Schriek, David Falck, Manfred Wuhrer, et al.
Antiviral Research (2024), pp. 106015-106015
Open Access | Times Cited: 1
A diverse collection of B cells responded to HIV infection in infant BG505
Cassandra A. Simonich, Mackenzie M. Shipley, Laura Doepker, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 6, pp. 100314-100314
Open Access | Times Cited: 12
Antibodies for Human Immunodeficiency Virus-1 Cure Strategies
Evan Rossignol, Galit Alter, Boris Jülg
The Journal of Infectious Diseases (2020) Vol. 223, Iss. Supplement_1, pp. S22-S31
Open Access | Times Cited: 12
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features
Hao Cheng, Karen G. Dowell, Chris Bailey‐Kellogg, et al.
Retrovirology (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top